Researchers tell us that it’s the technology that drives the innovations and breakthroughs in cancer research. Since 1984 we have provided $171 million to 81 projects within 43 organisations through the generosity of all our supporters working together towards a world without cancer.
The ACRF Medical Research Advisory Committee comprises world-renowned scientists and clinicians who ensure only the most deserving of projects are funded. Ultimately this gives you comfort that your donation will result in real, measurable benefits for those diagnosed with or at risk of cancer.
With input from health economics specialists, we have developed a model to articulate the impact of our supported projects. This will help you understand the value of your support and how it contributes socially, scientifically and economically.
You can choose how much or how little you want to be involved, and where your money goes – to one or more projects. A minimum contribution of $5,000 is required per project. Or you can share your contribution across all projects through ‘untied funding’.
We’ll keep you informed of progress, but you may want to go a little deeper in your understanding of the research by attending special events and tours. Your dedicated relationship manager will tailor your preferences in line with your wishes.
A world-first project engaging physics and engineering talent to build two Australian-designed microscopes. These will enable researchers to see deeper inside tissues at resolutions currently not possible. Deep biological insights are needed to realise the full potential of cancer immunotherapy to cure all cancers.
“By looking in the ‘dark space’ deep inside tumours, we hope to finally answer questions that we have not been able to answer before, revealing crucial insights that will allow us to develop new therapeutic approaches for eradicating cancer in all patients.”
This new Glycomics Centre will focus on generating new knowledge that will advance our understanding of cancer glycobiology and enable the translation of this knowledge into the next generation precision diagnostics and therapies to fight cancer, which impacts millions of patients and their families globally.
“This research will provide major advances in the early diagnosis of significant cancers, including skin, ovarian and breast cancer. The discovery and development of new drugs to treat these cancers will be another major outcome of this grant.”
A Queensland-based, world-first mobile lung cancer research facility focused on early detection research for lung cancer – the leading cause of cancer deaths globally. This pilot program will develop and test a mobile, multi-platform lung cancer detection centre with the aim of reducing health disparities. It will ensure access to rural and remote communities and at-risk populations to ensure equal opportunity for all.
“We have learned from other researchers that trucks can be an alternative way of reaching people who are at risk of lung cancer, to help with screen early detection. This comes from important work in the UK, where trucks have been shown to improve the participation rate, and to allow people to be diagnosed and cured of lung cancer early.”
The new ACRF Molecular Theranostics Laboratory will house world-leading research into the use of theranostics to treat cancer. A form of personalised cancer treatment for the patient, the term ‘theranostics’ refers to a combined therapy and diagnostics approach. An exciting and emerging field, theranostics has the potential to revolutionise cancer treatment, employing tumour markers to deliver a therapeutic isotope (radioactive drug) directly to tumour cells to kill them.
“Researchers at the ACRF Molecular Theranostics Laboratory have devised a theranostic approach that we hope will work against all types of solid tumours. It has an inbuilt self-amplifying mechanism of action, meaning that it should become substantially more effective with each administration.”
If you, like us, believe a world without cancer is possible, please help us in Backing Brilliant scientists and projects to make it happen.